Schramm (born November 9, 1941) is a Professor & Ruth Merns Chair in Biochemistry at the Albert Einstein College of Medicine of Yeshiva University.
Schramm was elected to the National Academy of Sciences in 2007.
His laboratory's research focuses on the elucidation of enzymatic mechanisms and transition state structure.This information is then used for the logical design of transition-state inhibitors which have the potential to be new biologically active agents.
Some of these are in development to be drugs.
Schramm's work has translated basic chemical understanding at the quantum mechanical level to a new approach to drug development.